Abstracts

Plerixafor vs G-CSF: Graft Stem Cells Composition in HSCT with αβ T Depletion in Pediatric Cohort

Abstract

Introduction: Hematopoietic stem cells (SC) are a heterogeneous population including the early-uncommitted fraction as well as different committed subsets. Donor mobilization strategy seems to be a significant factor affecting SC composition and engraftment kinetics. The aim of this study was to investigate the impact of different mobilization protocols: G-CSF (GCSF) or G-CSF with Plerixafor in case of inadequate stimulation with G-CSF alone (Plerixafor) on SC composition in a large cohort of pediatric patients transplanted from allo-compatible donors with αβ T cells depletion.

Methodology: Specimens from 161 grafts – 31 Plerixafor (19.3%) and 130 GCSF (80.7%) were under investigation. The samples were immunophenotyped by flow cytometry: pluripotent hematopoietic stem cells (HSC) –CD45RA-CD34+CD90+, multipotent progenitor (MPP) – CD45RA-CD34+CD90-CD133+, lymphoid-primed multipotent progenitor – (LMPP) – CD45RA+CD133+CD34+CD38lowCD10-, late granulocytes and macrophages progenitor – (late GMP) – CD45RA+CD133+CD34+CD38+CD10-, multi-lymphoid progenitor – (MLP) – CD45RA+CD133+CD34+CD38+CD10+, B-lymphoid progenitor – (BLP) – CD45RA+CD133-CD34+CD38++CD10+CD19+ and erythro-myeloid progenitor – (EMP) – CD45RA-CD34+CD133-CD10- CD38+ (J Dmytrus et. Al. 2016).

Differences were assessed using Mann-Whitney test. The engraftment was assessed using the data of leukocytes (WBC) and thrombocytes (PLT) engraftment (days WBC 1*106/ml, PLT 20*10^6/ml).

Results: Evaluation of CD34 subtypes revealed significant differences in Plerixafor and GCSF cohort respectively: HSC (M – 7.99% and 3.5%, p<0.0001); MPP (M – 54.26% and 66.12 %, p<0.0001); LMPP (M – 22.64% and 16.55%, p<0.0001); late GMP (M – 0.81% and 0.26%, p<0.0001); MLP (M – 2.24% and 0.78%, p<0.0001); BLP (M – 0.67% and 0.12%, p<0.0001); EMP (M – 0.95% and 0.65%, ns). The study of the correlation between the number of cells from various subpopulations and the engraftment time did not reveal significant differences.

Conclusion: The observed differences in the composition of SC subpopulations may be due to different mobilization strategies. However, these differences have not affected the effectiveness or timing of engraftment.

How to Cite

Fadeeva M, Glushkova S, Lodoeva O, Vedmedskaia V, Sozonova T, Malakhova E, et al. Plerixafor vs G-CSF: Graft Stem Cells Composition in HSCT with αβ T Depletion in Pediatric Cohort. OncoDaily Med J. 2025. doi:10.69690/ODMJ-018-0425-1212